5-bromo-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;5-bromo-2H-pyrazolo[3,4-b]pyridine-3-carboxylic acid;5-[2-(cyclopropanecarbonylamino)-1,3-benzothiazol-6-yl]-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;deca-1,3,5,7,9-pentayne;methane;oxan-4-amine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide

C76H81BBr2N16O11S2 — CID 165042743

IUPAC5-bromo-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;5-bromo-2H-pyrazolo[3,4-b]pyridine-3-carboxylic acid;5-[2-(cyclopropanecarbonylamino)-1,3-benzothiazol-6-yl]-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;deca-1,3,5,7,9-pentayne;methane;oxan-4-amine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide
SMILESC.C.C#CC#CC#CC#CC#C.CC1(C)OB(c2ccc3nc(NC(=O)C4CC4)sc3c2)OC1(C)C.NC1CCOCC1.O=C(NC1CCOCC1)c1[nH]nc2ncc(-c3ccc4nc(NC(=O)C5CC5)sc4c3)cc12.O=C(NC1CCOCC1)c1[nH]nc2ncc(Br)cc12.O=C(O)c1[nH]nc2ncc(Br)cc12
InChIInChI=1S/C23H22N6O3S.C17H21BN2O3S.C12H13BrN4O2.C10H2.C7H4BrN3O2.C5H11NO.2CH4/c30-21(12-1-2-12)27-23-26-17-4-3-13(10-18(17)33-23)14-9-16-19(28-29-20(16)24-11-14)22(31)25-15-5-7-32-8-6-15;1-16(2)17(3,4)23-18(22-16)11-7-8-12-13(9-11)24-15(19-12)20-14(21)10-5-6-10;13-7-5-9-10(16-17-11(9)14-6-7)12(18)15-8-1-3-19-4-2-8;1-3-5-7-9-10-8-6-4-2;8-3-1-4-5(7(12)13)10-11-6(4)9-2-3;6-5-1-3-7-4-2-5;;/h3-4,9-12,15H,1-2,5-8H2,(H,25,31)(H,24,28,29)(H,26,27,30);7-10H,5-6H2,1-4H3,(H,19,20,21);5-6,8H,1-4H2,(H,15,18)(H,14,16,17);1-2H;1-2H,(H,12,13)(H,9,10,11);5H,1-4,6H2;2*1H4
InChIKeyOJXGHEPOHRDHHI-UHFFFAOYSA-N
MW1629.34 g/mol
LogP11.14
Rot. Bonds11

About 5-bromo-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;5-bromo-2H-pyrazolo[3,4-b]pyridine-3-carboxylic acid;5-[2-(cyclopropanecarbonylamino)-1,3-benzothiazol-6-yl]-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;deca-1,3,5,7,9-pentayne;methane;oxan-4-amine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide

5-bromo-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;5-bromo-2H-pyrazolo[3,4-b]pyridine-3-carboxylic acid;5-[2-(cyclopropanecarbonylamino)-1,3-benzothiazol-6-yl]-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;deca-1,3,5,7,9-pentayne;methane;oxan-4-amine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide (PubChem CID 165042743) has the molecular formula C76H81BBr2N16O11S2 and a molecular weight of 1629.34 g/mol. Its IUPAC name is 5-bromo-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;5-bromo-2H-pyrazolo[3,4-b]pyridine-3-carboxylic acid;5-[2-(cyclopropanecarbonylamino)-1,3-benzothiazol-6-yl]-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;deca-1,3,5,7,9-pentayne;methane;oxan-4-amine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide.

Molecular Properties

Compound Name5-bromo-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;5-bromo-2H-pyrazolo[3,4-b]pyridine-3-carboxylic acid;5-[2-(cyclopropanecarbonylamino)-1,3-benzothiazol-6-yl]-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;deca-1,3,5,7,9-pentayne;methane;oxan-4-amine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide
PubChem CID165042743
Molecular FormulaC76H81BBr2N16O11S2
Molecular Weight1629.34 g/mol
Exact Mass1626.42
IUPAC Name5-bromo-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;5-bromo-2H-pyrazolo[3,4-b]pyridine-3-carboxylic acid;5-[2-(cyclopropanecarbonylamino)-1,3-benzothiazol-6-yl]-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;deca-1,3,5,7,9-pentayne;methane;oxan-4-amine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide
SMILESC.C.C#CC#CC#CC#CC#C.CC1(C)OB(c2ccc3nc(NC(=O)C4CC4)sc3c2)OC1(C)C.NC1CCOCC1.O=C(NC1CCOCC1)c1[nH]nc2ncc(-c3ccc4nc(NC(=O)C5CC5)sc4c3)cc12.O=C(NC1CCOCC1)c1[nH]nc2ncc(Br)cc12.O=C(O)c1[nH]nc2ncc(Br)cc12
InChIInChI=1S/C23H22N6O3S.C17H21BN2O3S.C12H13BrN4O2.C10H2.C7H4BrN3O2.C5H11NO.2CH4/c30-21(12-1-2-12)27-23-26-17-4-3-13(10-18(17)33-23)14-9-16-19(28-29-20(16)24-11-14)22(31)25-15-5-7-32-8-6-15;1-16(2)17(3,4)23-18(22-16)11-7-8-12-13(9-11)24-15(19-12)20-14(21)10-5-6-10;13-7-5-9-10(16-17-11(9)14-6-7)12(18)15-8-1-3-19-4-2-8;1-3-5-7-9-10-8-6-4-2;8-3-1-4-5(7(12)13)10-11-6(4)9-2-3;6-5-1-3-7-4-2-5;;/h3-4,9-12,15H,1-2,5-8H2,(H,25,31)(H,24,28,29)(H,26,27,30);7-10H,5-6H2,1-4H3,(H,19,20,21);5-6,8H,1-4H2,(H,15,18)(H,14,16,17);1-2H;1-2H,(H,12,13)(H,9,10,11);5H,1-4,6H2;2*1H4
InChIKeyOJXGHEPOHRDHHI-UHFFFAOYSA-N
XLogP11.14
TPSA376.36 Ų
H-Bond Donors9
H-Bond Acceptors21
Rotatable Bonds11
Heavy Atoms108
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001629.34
LogP ≤ 511.14
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze 5-bromo-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;5-bromo-2H-pyrazolo[3,4-b]pyridine-3-carboxylic acid;5-[2-(cyclopropanecarbonylamino)-1,3-benzothiazol-6-yl]-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;deca-1,3,5,7,9-pentayne;methane;oxan-4-amine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-bromo-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;5-bromo-2H-pyrazolo[3,4-b]pyridine-3-carboxylic acid;5-[2-(cyclopropanecarbonylamino)-1,3-benzothiazol-6-yl]-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;deca-1,3,5,7,9-pentayne;methane;oxan-4-amine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide?
The IUPAC name of 5-bromo-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;5-bromo-2H-pyrazolo[3,4-b]pyridine-3-carboxylic acid;5-[2-(cyclopropanecarbonylamino)-1,3-benzothiazol-6-yl]-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;deca-1,3,5,7,9-pentayne;methane;oxan-4-amine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide (CID 165042743) is 5-bromo-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;5-bromo-2H-pyrazolo[3,4-b]pyridine-3-carboxylic acid;5-[2-(cyclopropanecarbonylamino)-1,3-benzothiazol-6-yl]-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;deca-1,3,5,7,9-pentayne;methane;oxan-4-amine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide.
What is the SMILES notation for 5-bromo-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;5-bromo-2H-pyrazolo[3,4-b]pyridine-3-carboxylic acid;5-[2-(cyclopropanecarbonylamino)-1,3-benzothiazol-6-yl]-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;deca-1,3,5,7,9-pentayne;methane;oxan-4-amine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide?
The canonical SMILES for 5-bromo-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;5-bromo-2H-pyrazolo[3,4-b]pyridine-3-carboxylic acid;5-[2-(cyclopropanecarbonylamino)-1,3-benzothiazol-6-yl]-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;deca-1,3,5,7,9-pentayne;methane;oxan-4-amine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide is C.C.C#CC#CC#CC#CC#C.CC1(C)OB(c2ccc3nc(NC(=O)C4CC4)sc3c2)OC1(C)C.NC1CCOCC1.O=C(NC1CCOCC1)c1[nH]nc2ncc(-c3ccc4nc(NC(=O)C5CC5)sc4c3)cc12.O=C(NC1CCOCC1)c1[nH]nc2ncc(Br)cc12.O=C(O)c1[nH]nc2ncc(Br)cc12.
What is the InChIKey of 5-bromo-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;5-bromo-2H-pyrazolo[3,4-b]pyridine-3-carboxylic acid;5-[2-(cyclopropanecarbonylamino)-1,3-benzothiazol-6-yl]-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;deca-1,3,5,7,9-pentayne;methane;oxan-4-amine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide?
The InChIKey is OJXGHEPOHRDHHI-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H22N6O3S.C17H21BN2O3S.C12H13BrN4O2.C10H2.C7H4BrN3O2.C5H11NO.2CH4/c30-21(12-1-2-12)27-23-26-17-4-3-13(10-18(17)33-23)14-9-16-19(28-29-20(16)24-11-14)22(31)25-15-5-7-32-8-6-15;1-16(2)17(3,4)23-18(22-16)11-7-8-12-13(9-11)24-15(19-12)20-14(21)10-5-6-10;13-7-5-9-10(16-17-11(9)14-6-7)12(18)15-8-1-3-19-4-2-8;1-3-5-7-9-10-8-6-4-2;8-3-1-4-5(7(12)13)10-11-6(4)9-2-3;6-5-1-3-7-4-2-5;;/h3-4,9-12,15H,1-2,5-8H2,(H,25,31)(H,24,28,29)(H,26,27,30);7-10H,5-6H2,1-4H3,(H,19,20,21);5-6,8H,1-4H2,(H,15,18)(H,14,16,17);1-2H;1-2H,(H,12,13)(H,9,10,11);5H,1-4,6H2;2*1H4.
What are the key properties of 5-bromo-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;5-bromo-2H-pyrazolo[3,4-b]pyridine-3-carboxylic acid;5-[2-(cyclopropanecarbonylamino)-1,3-benzothiazol-6-yl]-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;deca-1,3,5,7,9-pentayne;methane;oxan-4-amine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide?
5-bromo-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;5-bromo-2H-pyrazolo[3,4-b]pyridine-3-carboxylic acid;5-[2-(cyclopropanecarbonylamino)-1,3-benzothiazol-6-yl]-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;deca-1,3,5,7,9-pentayne;methane;oxan-4-amine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide has a molecular weight of 1629.34 g/mol, XLogP of 11.14, 11 rotatable bonds, 9 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 5-bromo-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;5-bromo-2H-pyrazolo[3,4-b]pyridine-3-carboxylic acid;5-[2-(cyclopropanecarbonylamino)-1,3-benzothiazol-6-yl]-N-(oxan-4-yl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide;deca-1,3,5,7,9-pentayne;methane;oxan-4-amine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide is sourced from PubChem (CID 165042743), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).